Remote Ischemic Conditioning for Preventing and Treating Ischemic Stroke
Wenbo Zhao,Jing Zhang,Mordechai Sadowsky,Ran Meng,Yuchuan Ding,Xunming Ji
DOI: https://doi.org/10.1161/strokeaha.118.023091
IF: 10.17
2018-01-01
Stroke
Abstract:HomeStrokeVol. 49, No. 12Remote Ischemic Conditioning for Preventing and Treating Ischemic Stroke Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBRemote Ischemic Conditioning for Preventing and Treating Ischemic Stroke Wenbo Zhao, MD, Jing Zhang, MD, Mordechai Sadowsky, MD, Ran Meng, MD, Yuchuan Ding, PhD and Xunming Ji, MD Wenbo ZhaoWenbo Zhao From the Department of Neurology (W.Z., J.Z., R.M.), Xuanwu Hospital, Capital Medical University, Beijing, China , Jing ZhangJing Zhang From the Department of Neurology (W.Z., J.Z., R.M.), Xuanwu Hospital, Capital Medical University, Beijing, China , Mordechai SadowskyMordechai Sadowsky Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI (M.S., Y.D.). , Ran MengRan Meng From the Department of Neurology (W.Z., J.Z., R.M.), Xuanwu Hospital, Capital Medical University, Beijing, China , Yuchuan DingYuchuan Ding Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI (M.S., Y.D.). and Xunming JiXunming Ji Correspondence to Xunming Ji, MD, Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun St, Xicheng, Beijing 100053, China. Email E-mail Address: [email protected] Department of Neurosurgery (X.J.), Xuanwu Hospital, Capital Medical University, Beijing, China Originally published24 Sep 2018https://doi.org/10.1161/STROKEAHA.118.023091Stroke. 2018;49:e327–e328Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: September 24, 2018: Ahead of Print Clinical studies have suggested that remote ischemic conditioning (RIC) may have beneficial effects in patients with ischemic stroke (IS) and those at risk of IS. However, existing evidence is insufficient to demonstrate the efficacy and safety of RIC in preventing and treating IS, warranting this meta-analysis.1ObjectivesWe aimed to assess the benefits and harms of RIC for preventing and treating IS.MethodsWe searched the Cochrane Stroke Group Trials Register, CENTRAL (Cochrane Central Register of Controlled Trials), MEDLINE, Embase, Web of Science Core Collection, and 3 additional databases, as well as trial registries, up to January 2018. We included randomized controlled trials comparing RIC with non-RIC in patients with IS or at risk of IS.Main ResultsWe included 7 trials with a total of 735 participants. Three trials, involving 371 participants, analyzed effects of RIC on IS prevention. In patients with symptomatic intracerebral artery stenosis, recurrent IS was significantly reduced by RIC (risk ratio, 0.32; 95% CI, 0.12–0.83; Figure [A]). In patients undergoing carotid stenting, pretreatment of RIC significantly lower stroke severity (mean difference, −0.17 mL; 95% CI, −0.23 to −0.11). However, adverse events were significantly higher in participants treated with RIC (risk ratio, 10.91; 95% CI, 2.01–59.28).Download figureDownload PowerPointFigure. Forest plot is comparing remote ischemic conditioning (RIC) and non-RIC for (A) preventing and (B) treating ischemic stroke (death or dependency).Four trials, involving 364 participants, analyzed effects of RIC on IS treatment. In patients with acute stroke undergoing intravenous thrombolysis, the death or dependency rate was significantly associated with RIC (risk ratio, 2.34; 95% CI, 1.19–4.61; Figure [B]). RIC did not significantly affect stroke severity (standardized mean difference, −0.24 mL; 95% CI, −1.02 to 0.54), psychological (standardized mean difference, −0.37 points; 95% CI, −1.15 to 0.41), and cognitive function (standardized mean difference, −0.26 points; 95% CI, −0.72 to 0.21).ConclusionsBased on the current low-quality evidence from several small trials, it is difficult to determine whether patients will benefit from RIC. Results must be interpreted with caution because of the small number of studies and low quality of evidence. Future studies are needed to confirm or refute any effects of RIC in preventing and treating IS.DisclosuresDr Ji is one of the inventors of the electric autocontrol device that can perform remote ischemic conditioning. The other authors report no conflicts.FootnotesThis article is based on a Cochrane Review published in The Cochrane Library 2018, Issue 7 (see www.thecochranelibrary.com for information). Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, and The Cochrane Library should be consulted for the most recent version of the review.Correspondence to Xunming Ji, MD, Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun St, Xicheng, Beijing 100053, China. Email [email protected]edu.cnReference1. Zhao W, Zhang J, Sadowsky MG, Meng R, Ding Y, Ji X. Remote ischaemic conditioning for preventing and treating ischaemic stroke.Cochrane Database Syst Rev. 2018; 7:CD012503. doi: 10.1002/14651858.CD012503.pub2MedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails December 2018Vol 49, Issue 12 Advertisement Article InformationMetrics © 2018 American Heart Association, Inc.https://doi.org/10.1161/STROKEAHA.118.023091 Manuscript receivedAugust 9, 2018Manuscript acceptedAugust 23, 2018Originally publishedSeptember 24, 2018Manuscript revisedAugust 9, 2018 Keywordsmeta-analysisstrokesafetytreatment outcometherapeuticsPDF download Advertisement SubjectsCerebrovascular Disease/StrokeClinical StudiesIschemic Stroke